Literature DB >> 10422804

Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry.

O Loubser1, A D Marais, M J Kotze, N Godenir, R Thiart, C L Scholtz, J N de Villiers, R Hillermann, J C Firth, H F Weich, F Maritz, S Jones, D R van der Westhuyzen.   

Abstract

The South African population harbors genes that are derived from varying degrees of admixture between indigenous groups and immigrants from Europe and the East. This study represents the first direct mutation-based attempt to determine the impact of admixture from other gene pools on the familial hypercholesterolemia (FH) phenotype in the recently founded Coloured population of South Africa, a people of mixed ancestry. A cohort of 236 apparently unrelated patients with clinical features of FH was screened for a common mutation causing familial defective apolipoprotein B-100 (FDB) and seven low-density lipoprotein receptor (LDLR) gene defects known to be relatively common in South Africans with FH. Six founder-type 'South African mutations' were responsible for FH in approximately 20% of the study population, while only 1 patient tested positive for the familial defective apolipoprotein B-100 mutation R3500Q. The detection of multiple founder-type LDLR gene mutations originating from European, Indian and Jewish populations provides direct genetic evidence that Caucasoid admixture contributes significantly to the apparently high prevalence of FH in South African patients of mixed ancestry. This study contributes to our knowledge of the biological history of this unique population and illustrates the potential consequences of recent admixture in populations with different disease risks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422804     DOI: 10.1034/j.1399-0004.1999.550507.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia.

Authors:  Renate Hillermann; Kashefa Carelse; G Stefan Gebhardt
Journal:  J Hum Genet       Date:  2005-07-30       Impact factor: 3.172

3.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

4.  Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation.

Authors:  A J Wigg; H Harley; G Casey
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

5.  Simultaneous detection of multiple familial hypercholesterolemia mutations facilitates an improved diagnostic service in South african patients at high risk of cardiovascular disease.

Authors:  Maritha J Kotze; Gernot Kriegshäuser; Rochelle Thiart; Nico J P de Villiers; Charlotte L Scholtz; Fritz Kury; Anne Moritz; Christian Oberkanins
Journal:  Mol Diagn       Date:  2003

6.  Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.

Authors:  Ana Margarida Medeiros; Ana Catarina Alves; Pedro Aguiar; Mafalda Bourbon
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

7.  Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.

Authors:  Shi-Jun Deng; Adekunle Alabi; Hong-Mei Gu; Ayinuer Adijiang; Shucun Qin; Da-Wei Zhang
Journal:  J Lipid Res       Date:  2019-01-07       Impact factor: 5.922

8.  Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.

Authors:  K Widhalm; A Dirisamer; A Lindemayr; G Kostner
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.